Release Date: 28/05/10 13:52 Summary: Chairman's Address to Shareholders (Revised) Price Sensitive: No Download Document 19.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%